Bergera euchrestifolia
Bergera euchrestifolia · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Bergera euchrestifolia is a unique plant species that has garnered significant interest in pharmacological research. Scientific investigations have identified several potent bioactive compounds within its chemical profile, most notably girinimbine, murrayafoline A, and murrayazolinine. These specific alkaloids are of particular interest due to their diverse biological properties and therapeutic potential. Recent studies have highlighted the plant's notable antiplatelet activities, suggesting its utility in cardiovascular health management. Consequently, this species serves as a promising natural source for developing new medicinal agents.
- Synonyms
- Murraya Euchrestifolia · Chalcas Euchrestifolia · 1 more
- Common names
- Not available
- Family
- Rutaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Not available
Classification
Common Names
Bergera euchrestifolia is a unique plant recognized by several distinct common names across different regions. In some areas, it is affectionately referred to as アカミゲッキツ, highlighting its specific botanical character. It is also known by the name 山豆葉月橘, showcasing its linguistic diversity. Furthermore, the species is frequently called 山黃皮 or 山黄皮 depending on the local dialect or transcription style used. These various names reflect the rich cultural and regional ways in which this plant is identified.
Sources: Catalogue of Life (COL)
Synonyms
Bergera euchrestifolia is a botanical species that is frequently identified by various alternative names within scientific literature. Due to historical classification shifts, it is recognized by the synonym Chalcas euchrestifolia. Researchers may also encounter it documented under the name Clausena euchrestifolia in older texts. Furthermore, the plant has been associated with the synonym Murraya euchrestifolia in certain taxonomic contexts. Understanding these various nomenclatural relationships is essential for accurate identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bergera euchrestifolia is a fascinating specimen that belongs to the kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. Its taxonomic journey continues through the order Sapindales, showcasing its evolutionary connections. Furthermore, this plant is a proud member of the Rutaceae family, which defines many of its botanical characteristics. Ultimately, it is distinguished by its placement within the unique genus Bergera.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Rutaceae |
| Genus | Bergera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bergera euchrestifolia is a plant species primarily distributed across the temperate regions of Asia. Its presence is notably recorded throughout various parts of China, including the South-Central and Southeast provinces. The species also finds a specific habitat on the island of Hainan. Furthermore, its range extends into Eastern Asia, specifically encompassing the island of Taiwan. These diverse locations highlight the botanical footprint of the species across the Asian landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Bergera euchrestifolia contains a valuable compound known as girinimbine that demonstrates significant antiplatelet activity. Research indicates that this agent works by inhibiting cyclooxygenase activity and increasing platelet cyclic AMP levels. Specifically, girinimbine has been shown to inhibit platelet aggregation induced by various factors, including arachidonic acid and collagen, in a concentration-dependent manner. It also selectively targets secondary aggregation and the release of ATP within human platelet-rich plasma. These findings highlight the plant's potential role in managing blood clotting processes through complex biochemical pathways.
Compounds
Bergera euchrestifolia serves as a rich source of diverse bioactive alkaloids with significant pharmacological potential. One notable compound found within the plant is girinimbine, which functions as an effective antiplatelet agent by inhibiting cyclooxygenase activity. Additionally, the species contains murrayafoline A, a carbazole alkaloid identified for its ability to suppress cancer cell growth. Research also highlights the presence of murrayazolinine, which similarly induces apoptosis in human leukemia cells through specific caspase pathways. Together, these chemical constituents demonstrate the complex medicinal properties inherent to this botanical species.
Conditions
Bergera euchrestifolia, through its isolated compounds like girinimbine, treats HL-60 leukemia cells by inducing apoptosis via the caspase-9/caspase-3 pathway. The plant also serves as an antiplatelet agent that treats U46619-induced aggregation in rabbit platelets. Additionally, its bioactive components treat ATP release by inhibiting it in a concentration-dependent manner. These substances further treat platelet cyclic AMP levels by elevating them at high concentrations. Finally, the plant treats [3H]inositol monophosphate generation by inhibiting its production when stimulated by arachidonic acid and collagen.